A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo
Name:
Publisher version
UMass Chan Affiliations
Department of Quantitative Health SciencesDepartment of Medicine, Division of Dermatology
Document Type
Letter to the EditorPublication Date
2017-01-01Metadata
Show full item recordAbstract
We conducted a small, randomized, double-blind, placebo-controlled, phase II clinical trial to test simvastatin as a treatment for vitiligo.Source
J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015. Link to article on publisher's site